| Product NDC: | 51808-217 |
| Proprietary Name: | Bicisate |
| Non Proprietary Name: | Bicisate |
| Active Ingredient(s): | 1.35 mg/1 & nbsp; Bicisate |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 51808-217 |
| Labeler Name: | AnazaoHealth Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Start Marketing Date: | 20120523 |
| Package NDC: | 51808-217-01 |
| Package Description: | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 KIT (51808-217-01) |
| NDC Code | 51808-217-01 |
| Proprietary Name | Bicisate |
| Package Description | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 KIT (51808-217-01) |
| Product NDC | 51808-217 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Bicisate |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20120523 |
| Marketing Category Name | UNAPPROVED DRUG OTHER |
| Labeler Name | AnazaoHealth Corporation |
| Substance Name | BICISATE |
| Strength Number | 1.35 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |